Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Economic evaluations of inactivated COVID-19 vaccines in six Western Pacific and South East Asian countries and regions: A modeling study
Yawen Jiang, Dan Cai, Si Shi
Infectious Disease Modelling (2021) Vol. 7, Iss. 1, pp. 109-121
Open Access | Times Cited: 15

Showing 15 citing articles:

Economic evaluation of COVID-19 vaccination: A systematic review
Auliasari Utami, Farida Rendrayani, Qisty A Khoiry, et al.
Journal of Global Health (2023) Vol. 13
Open Access | Times Cited: 29
Cost-effectiveness of interventions for the prevention and control of COVID-19: Systematic review of 85 modelling studies
Lihui Zhou, Wenxin Yan, Shu Li, et al.
Journal of Global Health (2022) Vol. 12
Open Access | Times Cited: 35
Cost‐effectiveness of COVID‐19 vaccination: A systematic review
Yaqun Fu, Jingyu Zhao, Peien Han, et al.
Journal of Evidence-Based Medicine (2023) Vol. 16, Iss. 2, pp. 152-165
Open Access | Times Cited: 20
Cost-effectiveness of preventive COVID-19 interventions: a systematic review and network meta-analysis of comparative economic evaluation studies based on real-world data
Xiaoyu Tang, Sun Sun, Mevludin Memedi, et al.
Journal of Global Health (2025) Vol. 15
Open Access
Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies
Yaqun Fu, Jingyu Zhao, Wei Xia, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 25
Analyzing the emerging patterns of SARS‐CoV‐2 Omicron subvariants for the development of next‐gen vaccine: An observational study
Ranjan K. Mohapatra, Snehasish Mishra, Venkataramana Kandi, et al.
Health Science Reports (2023) Vol. 6, Iss. 10
Open Access | Times Cited: 9
Incremental Net Benefit and Incremental Cost-Effectiveness Ratio of COVID-19 Vaccination Campaigns: Systematic Review of Cost-Effectiveness Evidence
G Santoli, Mario Cesare Nurchis, Giovanna Elisa Calabrò, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 347-347
Open Access | Times Cited: 8
Economic evaluation of vaccination against COVID‐19: A systematic review
Dolatshahi Zeinab, Shahin Nargesi, Mezginejad Fateme, et al.
Health Science Reports (2024) Vol. 7, Iss. 2
Open Access | Times Cited: 2
Optimization of COVID-19 prevention and control measures during the Beijing 2022 Winter Olympics: a model-based study
Lingcai Kong, Mengwei Duan, Shi Jin, et al.
Infectious Diseases of Poverty (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 10
Economic Evaluation of COVID-19 Immunization Strategies: A Systematic Review and Narrative Synthesis
Enxue Chang, Haofei Li, Wanji Zheng, et al.
Applied Health Economics and Health Policy (2024) Vol. 22, Iss. 4, pp. 457-470
Closed Access | Times Cited: 1
Cost-Effectiveness of COVID-19 Sequential Vaccination Strategies in Inactivated Vaccinated Individuals in China
Yaqun Fu, Jingyu Zhao, Wei Xia, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1712-1712
Open Access | Times Cited: 7
Cost-effectiveness of COVID-19 vaccination in Latin America and the Caribbean: an analysis in Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Peru
Federico Augustovski, Ariel Bardach, Adrián Santoro, et al.
Cost Effectiveness and Resource Allocation (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Economic Evaluation of Covid-19 Vaccines: A Literature Review
Conghui Liu
Highlights in Business Economics and Management (2023) Vol. 3, pp. 197-203
Closed Access | Times Cited: 1
THE LONG-TERM SEROLOGICAL PROFILE OF CORONAVAC VACCINE BASED ON COMORBIDITIES AND HISTORY OF SARS-COV-2 INFECTION IN INDONESIA
Syahrul Chilmi, Tanti Adelia Kesuma, Purwa Adrianta Wibawa, et al.
Japanese Journal of Infectious Diseases (2023) Vol. 77, Iss. 1, pp. 40-46
Open Access | Times Cited: 1
Cost-effectiveness of COVID-19 vaccination in Latin America and the Caribbean: an analysis in Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Peru.
Federico Augustovski, Bardach Ariel, Adrián Santoro, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top